An immunosuppressant drug can 鈥渟upercharge鈥� checkpoint inhibitor therapy for Hodgkin鈥檚 lymphoma, researchers have reported.
The new combination is backed by both a phase I clinical trial and by preclinical studies.
The research involved the JAK in...
1 year ago
A European conference has heard of the latest, promising results from a trial of a new gene editing treatment for sickle cell.
18 patients have been taking part in the RUBY study. Researchers reported that all patients have been free of painful va...
1 year ago
